Last update 25 Feb 2026

OBT-893

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
OBT-893, SH-BC-893
Target
PP2A x S1PRs
Action
stimulants, agonists
Mechanism
PP2A stimulants(Protein phosphatase 2A stimulants), S1PRs agonists(Sphingosine 1-phosphate receptors agonists)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication-
Inactive Indication
Breast CancerCastration-Resistant Prostatic CancerColorectal Cancer+ [1]
Originator Organization
Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.
Active Organization-
Inactive Organization
Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with OBT-893
Login to view more data
100 Translational Medicine associated with OBT-893
Login to view more data
100 Patents (Medical) associated with OBT-893
Login to view more data
100 Deals associated with OBT-893
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPreclinical
United States
Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.
-
Castration-Resistant Prostatic CancerPreclinical
United States
Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.
-
Colorectal CancerPreclinical
United States
Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.
-
Pancreatic CancerPreclinical
United States
Obsidian Therapeutics, Inc.Obsidian Therapeutics, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free